The Keck School of Medicine of USC plans to open new cell therapy manufacturing facility. The facility will be located in USA.
The Keck School of Medicine at USC has secured a US$2 million grant from the California Institute of Regenerative Medicine (CIRM) to establish a cutting-edge facility.
This new state-of-the-art facility is designed to early-stage research toward the creation of practical and effective cell and gene therapies for clinical use. Moreover, the facility has been meticulously designed and equipped to facilitate cutting-edge investigations aimed at developing treatments that can be readily applied in clinical settings.
The facility aims to boost the lab's ability to pioneer cell therapy methods. With a focus on optimising both viral and non-viral manufacturing techniques, the lab will potentially spearhead innovative therapies, advancing the field significantly.
The investment will fuel the creation of a state-of-the-art infrastructure equipped with advanced technology, such as an electronic quality management system (eQMS).
The upcoming enhancements to the facility include the integration of an advanced electronic quality management system (eQMS), streamlining cell therapy manufacturing processes for optimal efficiency, and a strong focus the next wave of skilled professionals in this specialised field.
Name The Keck School of Medicine of USC
Type New Construction